3 Stocks That Are Reshaping the Future

11:04am, Tuesday, 16'th May 2023
Investors can find growth plays in many corners of the stock market, but  a smart play would be looking for the stocks reshaping the future. These are companies at the forefront of a burgeoning trend
Does Zimmer Biomet (ZBH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions records strong year-over-year sales growth at CER.
Zimmer Biomet (ZBH) came out with quarterly earnings of $1.89 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.61 per share a year ago.
Investors with an interest in Medical - Products stocks have likely encountered both Zimmer Biomet (ZBH) and LeMaitre Vascular (LMAT). But which of these two stocks offers value investors a better ban
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
While still sporting a modest year-to-date loss, the S&P 500 Health Care Index is higher by 4.44% over the past month, and with the healthcare sector's reputation for defensive and quality traits, it
Investors are optimistic about Zimmer Biomet's (ZBH) continued business recovery.
Zimmer Biomet (ZBH) might have faced an upheaval in business, thanks to the global inflationary situation in terms of mounting labor and raw material costs, severe staffing shortages and supply issues
ZBH vs. LMAT: Which Stock Is the Better Value Option?
ZBH vs. LMAT: Which Stock Is the Better Value Option?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. SYK, ZBH and HAE are well-poised
Each of Zimmer Biomet's (ZBH) geographic segments and product divisions record year-over-year sales growth at CER.
Zimmer Biomet Holdings Inc. (NYSE:ZBH ) Q4 2022 Earnings Conference Call February 3, 2023 8:30 AM ET Company Participants Bryan Hanson - President, Chief Executive Officer Suketu Upadhyay - Executive
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE